Primary malignant melanoma of the vagina: Case report and review of literature

Primary vaginal malignant melanoma is rare, with < 250 reported cases to date. It accounts for < 1% of all melanomas in women, < 10% of all female genital tract melanomas, and < 3% of all vaginal malignancies. Its clinical behavior is notoriously more aggressive than that of cutaneous and vulvar melanoma, with a 5-year survival rate ranging from 5% to 25%. Tumor size is the strongest predictor of survival, whereas tumor thickness is a weak predictor of survival. A case of F.I.G.O. stage I vaginal melanoma encircling and embracing the entire circumference of the middle third of the vagina is described. Tumor size and thickness were 6 cm and 9 mm, respectively. The patient was treated by wide local excision and pelvic radiotherapy, and to date, 11 months after surgery, she is alive and with no evidence of disease. It is concluded that wide local excision followed by pelvic radiotherapy is an appropriate treatment for melanoma confined to the vagina.

Vaginal malignancy; Wide local excision; Radiotherapy; Tumor size; Microstaging; Tumor thickness

[1] Weinstock M. A.: "Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival". Am. J. Obstet. Gynecol., 1994, 171, 1225.

[2] Buchanan D. J.. Schlaerth J., Kurosaki T.: "Primary vaginal melanoma: thirteen-year disease-free survival after wide local excision and review of recent literature". Am. J. Obst et. Gynecol., 1998, 178, 1177.

[3] Irvin W. P., Bliss S. A., Rice L. W., Taylor P. T., Andersen W. A.: "Malignant melanoma of the vagina and locoregional control radical surgery revisited". Gynecol. Oncol., 1998, 71, 476.

[4] Van Nostrand K. M., Lucci J. A. III. Schell M.. Berman M. L., Manetta A., Saia P. J.: "Primary vaginal melanoma: improved survival with radical pelvic surgery". Gynecol. Oneal., 1994, 55, 234.

[5] Cobellis L.,C alabrese E.,S tefanon B.. Raspagliesi F.: "Malignant melanoma of the vagina: report of 15 cases". Eur. J. Gynecol Oncol., 2000, 21, 295.

[6] Brown C. L.:''Surgical therapy of vaginal cancer: an overview" Update in Gynecolo gic Oncolo[;y, 1995, 16, 1.

[7] Petru E.. Nagele F., Czerwenka K., Graf A-H., Lax S., Bauer M et al.: "Primary malignant melanoma of the vagina: long-term remission following radiation therapy"Gynecol. Oneal., 1998. 70, 23.

[8] Rodier J. F.. Jancer J.C., David E., Routiot T., Ott G.: "Radiopharmaceutical-guided surgery in primary malignant melanoma of the vagina". Gynecol. Oneal., 1999, 75, 308.

[9] Creasman W. T., Phillips J. L., Menck H. R.: "The National Cancer Data Base report on cancer of the vagina". Cancer, 1998, 83, 1033.

[10] Reid G. C., Schmidt R. W., Robert、J. S., Hopkins M. P., Barret R J., Morley G. W.: "Primary melanoma of the vagina: a clinicopathologic analysis“ Ohstet. Gynecol.. 1989, 74, 190.

[11] Clark W. H. Jr, From L., Bernadino E. A., Mihm N. C.:'The histogenesis and biologic behaviour of primary human malignant me lanoma of the skin''. Cancer Res., 1969, 29, 705.

[12] Chung A. F.. Woodruff J. M., Lewis J. L. Jr.: "Malignant melanoma of the vulva: a report of 44 cases''. Ohstet. Gynecol., 1975, 45, 638.

[13] Breslow A:'Thickness, cross-sectional areas, and depth of mvasion in the prognosis of cutaneous melanoma". Ann. Surg., 1970, 172, 902.

[14] Geisler J.P., Look K. Y, Moore D. A.. Sutton G. P.: "Pelvic exenteration for malignant melanomas of the vagina or urethra with over 3 mm of invasion''. Gynecol. Oncol..1995, 59, 338.